Blair William & Co. IL Has $837,000 Holdings in Solventum Corporation (NYSE:SOLV)

Blair William & Co. IL reduced its position in Solventum Corporation (NYSE:SOLV) by 4.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,010 shares of the company’s stock after selling 552 shares during the period. Blair William & Co. IL’s holdings in Solventum were worth $837,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Natixis Advisors LLC increased its position in Solventum by 5.1% in the 1st quarter. Natixis Advisors LLC now owns 57,172 shares of the company’s stock worth $4,347,000 after purchasing an additional 2,766 shares during the last quarter. Seizert Capital Partners LLC acquired a new position in shares of Solventum during the 1st quarter valued at about $4,452,000. XTX Topco Ltd increased its holdings in shares of Solventum by 26.8% during the 1st quarter. XTX Topco Ltd now owns 6,417 shares of the company’s stock valued at $488,000 after acquiring an additional 1,356 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new position in shares of Solventum during the 1st quarter valued at about $49,000. Finally, MRP Capital Investments LLC increased its holdings in shares of Solventum by 12.4% during the 1st quarter. MRP Capital Investments LLC now owns 11,550 shares of the company’s stock valued at $878,000 after acquiring an additional 1,275 shares during the last quarter.

Solventum Price Performance

Shares of NYSE:SOLV opened at $73.34 on Monday. Solventum Corporation has a 1-year low of $56.69 and a 1-year high of $85.92. The firm has a market capitalization of $12.69 billion, a PE ratio of 33.95, a PEG ratio of 1.81 and a beta of 0.52. The business’s 50 day moving average is $74.21 and its 200-day moving average is $73.00. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.14.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Thursday, August 7th. The company reported $1.69 earnings per share for the quarter, topping the consensus estimate of $1.45 by $0.24. The company had revenue of $2.16 billion for the quarter, compared to analyst estimates of $2.12 billion. Solventum had a return on equity of 29.93% and a net margin of 4.52%. Solventum’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.56 EPS. Sell-side analysts predict that Solventum Corporation will post 6.58 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on SOLV shares. Argus raised Solventum from a “hold” rating to a “buy” rating and set a $90.00 price objective on the stock in a report on Tuesday, July 1st. Wells Fargo & Company increased their price objective on Solventum from $75.00 to $79.00 and gave the company an “equal weight” rating in a report on Friday. Morgan Stanley raised Solventum from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $80.00 to $103.00 in a report on Tuesday, July 15th. KeyCorp assumed coverage on Solventum in a report on Friday, June 6th. They set a “sector weight” rating on the stock. Finally, Piper Sandler increased their target price on Solventum from $87.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday. One research analyst has rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Solventum currently has a consensus rating of “Hold” and a consensus target price of $85.75.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.